We develop content for the successful reimbursement and prescription of drugs and devices.
We facilitate strategic development decisions in market access, in ways such as:
- analysing possible pricing scenarios
- proposing pricing and price negotiation strategies
- recommending value dossier content, and incorporating an HTA perspective
- probing intangible value
- economic evaluation
- Validating expectations on Return on Investment: informing about potential risks and mitigating threats
- Developing phase projects:
- Definition of most relevant outcomes
- Research & economic evaluation trials
- Facilitating appropriate development of PoC and Research Trials: Sites, KOL.
We support health start-ups
The last two months HiTT has been working in 2 different projects of innovative public purchase, this week we finally have present them to the regional health service call.read more
Dr. Solà-Morales has been selected to become one of the professors that will teach in this postgraduate study provided by the IQS (Instituto Químico de Sarrià).read more